Literature DB >> 17200709

A dominant role for glucose in beta cell compensation of insulin resistance.

Gordon C Weir1, Susan Bonner-Weir.   

Abstract

Increased insulin secretion and expansion of pancreatic beta cell mass work together to maintain normal glucose levels when insulin resistance develops. Changes in glucose concentration have long been known to have profound effects upon the rates of insulin secretion and beta cell mass, but various other agents can also cause changes, raising questions about which mechanisms are dominant. Evidence favoring a dominant role for glucose is provided by Terauchi et al. in this issue of the JCI (see the related article beginning on page 246). Mice haploinsufficient for beta cell glucokinase (Gck) were unable to increase their beta cell mass in response to insulin resistance produced by high-fat feeding. Gck is known to be the glucose sensor for glucose metabolism in beta cells. The study also provides strong evidence that insulin receptor substrate 2 (Irs2), which is known to have major effects on beta cell growth and survival, is a key downstream mediator of the effects of glucose found in this study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200709      PMCID: PMC1716221          DOI: 10.1172/JCI30862

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  Perspective: Postnatal pancreatic beta cell growth.

Authors:  S Bonner-Weir
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

2.  cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

Authors:  Ulupi S Jhala; Gianluca Canettieri; Robert A Screaton; Rohit N Kulkarni; Stan Krajewski; John Reed; John Walker; Xueying Lin; Morris White; Marc Montminy
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

3.  Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet beta-cell mass.

Authors:  C Miyaura; L Chen; M Appel; T Alam; L Inman; S D Hughes; J L Milburn; R H Unger; C B Newgard
Journal:  Mol Endocrinol       Date:  1991-02

4.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes.

Authors:  Kohjiro Ueki; Terumasa Okada; Jiang Hu; Chong Wee Liew; Anke Assmann; Gabriella M Dahlgren; Jennifer L Peters; Jonathan G Shackman; Min Zhang; Isabella Artner; Leslie S Satin; Roland Stein; Martin Holzenberger; Robert T Kennedy; C Ronald Kahn; Rohit N Kulkarni
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

6.  Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes.

Authors:  D Ross Laybutt; Gordon C Weir; Hideaki Kaneto; Judith Lebet; Richard D Palmiter; Arun Sharma; Susan Bonner-Weir
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

7.  Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells.

Authors:  Melissa K Lingohr; Isabelle Briaud; Lorna M Dickson; Jill F McCuaig; Cristina Alárcon; Barton L Wicksteed; Christopher J Rhodes
Journal:  J Biol Chem       Date:  2006-03-30       Impact factor: 5.157

8.  Regulatory effects of glucose on the catalytic activity and cellular content of glucokinase in the pancreatic beta cell. Study using cultured rat islets.

Authors:  C Chen; H Hosokawa; L M Bumbalo; J L Leahy
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats.

Authors:  H Hosokawa; Y A Hosokawa; J L Leahy
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

10.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  30 in total

1.  When the usual insulin is just not enough.

Authors:  Catherine E Gleason; Danielle N Gross; Morris J Birnbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-16       Impact factor: 11.205

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

4.  Developmental programming: Prenatal testosterone excess disrupts pancreatic islet developmental trajectory in female sheep.

Authors:  Ian J Jackson; Muraly Puttabyatappa; Miranda Anderson; Meha Muralidharan; Almudena Veiga-Lopez; Brigid Gregg; Sean Limesand; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-07-26       Impact factor: 4.102

5.  Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.

Authors:  Patrick Nelson; Noah Smith; Stanca Ciupe; Weiping Zou; Gilbert S Omenn; Massimo Pietropaolo
Journal:  Math Biosci Eng       Date:  2009-10       Impact factor: 2.080

6.  A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.

Authors:  Julio C Fraulob; Rebeca Ogg-Diamantino; Caroline Fernandes-Santos; Marcia Barbosa Aguila; Carlos A Mandarim-de-Lacerda
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

7.  Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2.

Authors:  Anke Assmann; Kohjiro Ueki; Jonathon N Winnay; Takahashi Kadowaki; Rohit N Kulkarni
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

8.  Ursolic acid and rosiglitazone combination improves insulin sensitivity by increasing the skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat diet-fed C57BL/6J mice.

Authors:  Arjunan Sundaresan; Thangaiyan Radhiga; Kodukkur Viswanathan Pugalendi
Journal:  J Physiol Biochem       Date:  2016-04-18       Impact factor: 4.158

9.  Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.

Authors:  Noriyuki Sonoda; Takeshi Imamura; Takeshi Yoshizaki; Jennie L Babendure; Juu-Chin Lu; Jerrold M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

10.  ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs.

Authors:  Hassan Mziaut; Stephan Kersting; Klaus-Peter Knoch; Wan-Hung Fan; Mirko Trajkovski; Katja Erdmann; Hendrik Bergert; Florian Ehehalt; Hans-Detlev Saeger; Michele Solimena
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.